Cost Plus Drugs inked deals with MultiCare Health System, Network Health, Blue Cross and Blue Shield insurers and others ...
An executive order by Trump rolled back some efforts by the Biden administration to control Medicare costs but it didn't change drug price caps.
Preclinical drug evaluation, especially for cardiotoxicity, is a critical stage in the drug development process.
The bill, which encompasses the recommendations of a task force, would regulate pharmacy benefit managers and increase price ...
A new fully automated in vivo screening system (AISS) has been developed to transform drug evaluation by enabling rapid, ...
On Tuesday in Hartford, a task force of legislators presented a series of recommendations to bring down the cost of ...
Screening and then characterizing all ... and can help to identify promising drug candidates faster and at lower cost than before. Monoclonal antibodies are one of the hottest classes of drugs ...